News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Bob Li Visited Jules Bordet Institute and Discussed Clinical Trial Access with Oncology Leaders
Bob Li/LinkedIn
Jun 12, 2025, 11:19

Bob Li Visited Jules Bordet Institute and Discussed Clinical Trial Access with Oncology Leaders

Bob Li, SVP Global Head of Medical Affairs, Oncology at AstraZeneca, shared a post on LinkedIn:

“Back in Europe this week for a MARS field visit to the Jules Bordet Institute in Brussels, an internationally-acclaimed cancer center that has pioneered molecular oncology and targeted cancer therapies.
It was great for our cross-functional team to catch up with the President of the Belgian Society of Medical Oncology, Professor Evandro de Azambuja and Dr Elisa Agostinetto for some truly energizing conversations about reinvigorating clinical trials and innovation across Europe.
We really dug into how innovation and decentralization can help us embed greater health equity into our work, and how partnerships to expand community access to clinical trials are moving forward our vision to transform cancer care. Thanks to our team in Belgium for facilitating such a great conversation MARS style!”

Jules Bordet Institute

More posts featuring the Jules Bordet Institute on OncoDaily.

AstraZeneca Belgian Society of Medical Oncology Bob Li cancer Elisa Agostinetto Evandro de Azambuja https://oncodaily.com/?search=&search_do_advanced=&s=Jules+Bordet+Institute Institut Jules Bordet Jules Bordet Institute MARS molecular oncology OncoDaily Oncology targeted cancer therapy
Special Coverage
Voices
Sep 5, 2025, 10:18
Isabel Mestres: I Recently Contributed with an Op-Ed to Resolve Global Health’s New Report
Dialogues
Sep 5, 2025, 10:12
MASCC 2025 Presidential Training Fellowship Spotlight: Celia Díez de los Ríos de la Serna
Voices
Sep 5, 2025, 10:11
Staying Physically Active Isn't Just Personal Care: It's Professional Responsibility - American Cancer Society
Voices
Sep 5, 2025, 09:55
Florian Lordick: Chemoresistance of Novel Therapeutic Approaches for Esophageal Adenocarcinoma
Science
Sep 5, 2025, 09:41
Vivek Subbiah: How Aggressive Brain Tumors Exploit Glucose to Suppress Normal Activity
Voices
Sep 5, 2025, 08:57
Honoring a Life of Compassion and Impact - CancerWorld
Voices
Sep 5, 2025, 08:57
C/Can Advances Breast Imaging Training for Global Cities
FDA Approvals
Sep 5, 2025, 08:44
Olomorasib Receives FDA Breakthrough Therapy Designation for KRAS G12C-Mutant NSCLC
Voices
Sep 5, 2025, 08:36
Miriam Mutebi: Scalpel-Wielding Surgeon is Terrified of Needles - Especially When They’re Aimed at Me
Dialogues
Sep 5, 2025, 08:09
ONCOFFEE: Gabriela Inés Villanueva – From Argentina to the US and Back, Shaping Pediatric Oncology
Dialogues
Sep 5, 2025, 08:07
Roche’s CMO Levi Garraway on Personal Journey, Developing Foundation Medicine, and Cancer Research
Dialogues
Sep 5, 2025, 08:05
What Happens When Cancer Meets a Global Pandemic? | Patient stories